Several major corporations have decided to rejoin the CBI as the lobby group makes strides in rebuilding its credibility and governance structures.Firms such as AstraZeneca, Unilever,…
GSK has sold part of its shareholding in its former consumer healthcare business, Haleon, raising around £885.6m. Haleon became an independent company listed on the London…
Biopharma company GSK has lifted its full-year guidance after reporting sales and earnings above expectations in the second quarter. Boosted by strong sales of its shingles…
Consumer goods group Unilever has indicated that it will continue to pursue a mega-merger with the health products business of GlaxoSmithKline (GSK). GSK has already said…
UK drug maker GlaxoSmithKline Plc (LON:GSK) said today it had increased its stake in its Indian unit GlaxoSmithKline Consumer Healthcare Ltd to 72.5% from 43.2%, as…
US biopharmaceutical firm Human Genome Sciences (NASDAQ:HGSI), or HGS, reiterated its advice to shareholders not to tender their stock to the $13.00 (EUR10.30) a share hostile…
British drugmaker GlaxoSmithKline Plc (LON:GSK) said it had added as a condition to its USD13.00 (EUR10.35) a share hostile takeover offer for Human Genome Sciences (NASDAQ:HGSI)…
The board of US biopharmaceutical firm Human Genome Sciences (NASDAQ:HGSI), or HGS, said on Thursday it had determined that the USD13.00 (EUR10.23) a share hostile takeover…
